A Novel Jaspine BCeramide Hybrid Modulates Sphingolipid Metabolism

Virginie Garcia,Pauline Le Faouder,Aude Dupuy,Thierry Levade,Stéphanie Ballereau,Yves Génisson,Pauline Le Faouder
DOI: https://doi.org/10.1002/cbdv.201400357
2015-07-01
Abstract:A new sphingolipid hybrid molecule was designed to assemble, within a tail-to-tail double-chain structure, the ceramide hydrophilic moiety and the tetrahydrofuran pharmacophore of jaspine B, a natural product known to interfere with sphingolipid metabolism. This compound was prepared through acylation of sphingosine with a jaspine B derivative bearing a COOH group in the terminal position of the aliphatic backbone. This new hybrid molecule was evaluated for its capacities to affect melanoma cell viability and sphingolipid metabolism. While retaining the cytotoxicity of ceramide itself, this compound was shown to lower the sphingomyelin cellular levels and significantly enhance the production of sphingosine-1-phosphate, thus representing a novel sphingolipid metabolism modulator.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?